Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-18

FDA Approved: AMBRISENTAN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ambrisentan submitted by Sun Pharmaceutical Industries, Inc. This marks an approved modification to the existing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ambrisentan (Ambrisentan)

Snippet

SUPPL AP for AMBRISENTAN (AMBRISENTAN)